4.5 Article

Costs of patient management over 18 months following a hip, clinical vertebral, distal forearm, or proximal humerus fragility fracture in France-results from the ICUROS study

期刊

OSTEOPOROSIS INTERNATIONAL
卷 33, 期 3, 页码 625-635

出版社

SPRINGER LONDON LTD
DOI: 10.1007/s00198-021-06189-7

关键词

Cost; Fracture; Hip; Medico-economic; Osteoporosis

资金

  1. Amgen
  2. Eli Lilly
  3. Medtronic
  4. Novartis
  5. Sanofi-Aventis
  6. Servier
  7. Pfizer

向作者/读者索取更多资源

This observational study in France prospectively evaluated the costs related to patient management over 18 months following hip, clinical vertebral, humeral, or distal forearm fracture events. The study found that these costs were much higher than previous estimates, increasing the burden of osteoporosis-related fractures on public health expenditures.
This observational study prospectively assessed direct and indirect costs related to patient management over 18 months following hip, clinical vertebral, humeral, or distal forearm fracture events in France. It appears that their levels were much higher than the previous estimates, raising the burden of osteoporosis-related fractures on public health expenditures. Introduction This prospective observational study assessed the costs related to patient management over the 18-month period following the event of a hip, clinical vertebral, humeral, or distal forearm fracture in France. Methods Individuals aged >= 50 years old with the diagnosis of a fragility fracture in six French University Hospitals were enrolled in the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS). All resources used over the defined period and related to fracture and the underlying osteoporosis management were collected by questionnaires at baseline, 4 months, 12 months, and 18 months. Information was collected by direct or phone contact completed by patients' records and interviews of partner, family, and general practitioners. Costs were estimated from a societal perspective, including direct and indirect costs. We implemented recursive partitioning analysis (RPA), a statistical learning algorithm to identify predictors of costs. Results Four hundred thirty-one patients (mean age 72.5 years; 84.6% women) were evaluated. Among them, 17.6% had a prior fracture in the last 5 years. Approximately half of the whole group lived alone in the community, and 56.8% were from a low- or middle-income category. Over the 18-month period of evaluation, total costs (including initial fracture-related and follow-up ones) were 23 926 euro, 14 561 euro, and 6 905 euro for the hip, clinical vertebral, and distal forearm fracture, respectively. Over a year, costs related to a humeral fracture were 10 319 euro. The RPA identified mobility impairment prior to fracture as a predictor of increase in costs related to fracture. Conclusions Our study for the first time prospectively assessed total costs related to the four main osteoporotic fractures in France. It appears that their levels were much higher than previous estimates, raising the burden of osteoporosis-related fractures on public health expenditures.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据